Literature DB >> 22474075

Herpes virus deneddylases interrupt the cullin-RING ligase neddylation cycle by inhibiting the binding of CAND1.

Stefano Gastaldello1, Simone Callegari, Giuseppe Coppotelli, Sebastian Hildebrand, Moshi Song, Maria G Masucci.   

Abstract

The conserved N-terminal domains of the major tegument proteins of herpes viridae encode cysteine proteases with potent ubiquitin and NEDD8-specific deconjugase activity. Here we show that the Epstein-Barr virus-encoded member of this enzyme family, BPLF1, is targeted to cullin-RING ubiquitin ligases (CRLs) via the interaction of the conserved helix-2 with helix-23 of the C-terminal domain (CTD) of cullins, at a site involved in electrostatic interaction with helix-8 of the CRL regulator CAND1. Mutation of the solvent-exposed Asp86 and Asp90 of helix-2 to Arg does not affect the enzymatic activity of BPLF1 but abolishes cullin binding and prevents CRL inactivation. The binding of the catalytically active BPLF1 to cullins inhibits the recruitment of CAND1 to the deneddylated CRLs and promotes the selective degradation of cullins by the proteasome. Cullin proteolysis is rescued by the overexpression of CAND1 or its CTD-binding N-terminal domain. These findings illustrate a new strategy for viral modulation of CRL activity where the combined effects of cullin deneddylation and their targeting for proteasomal degradation drive stable inactivation of the ligases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22474075     DOI: 10.1093/jmcb/mjs012

Source DB:  PubMed          Journal:  J Mol Cell Biol        ISSN: 1759-4685            Impact factor:   6.216


  11 in total

1.  The Rad6/18 ubiquitin complex interacts with the Epstein-Barr virus deubiquitinating enzyme, BPLF1, and contributes to virus infectivity.

Authors:  Ravindra Kumar; Christopher B Whitehurst; Joseph S Pagano
Journal:  J Virol       Date:  2014-03-26       Impact factor: 5.103

2.  Evolutionary conservation of primate lymphocryptovirus microRNA targets.

Authors:  Rebecca L Skalsky; Dong Kang; Sarah D Linnstaedt; Bryan R Cullen
Journal:  J Virol       Date:  2013-11-20       Impact factor: 5.103

3.  The Translesion Polymerase Pol η Is Required for Efficient Epstein-Barr Virus Infectivity and Is Regulated by the Viral Deubiquitinating Enzyme BPLF1.

Authors:  Ossie F Dyson; Joseph S Pagano; Christopher B Whitehurst
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

Review 4.  Deubiquitinating enzymes as promising drug targets for infectious diseases.

Authors:  Bindu Nanduri; Akamol E Suvarnapunya; Malabi Venkatesan; Mariola J Edelmann
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

5.  Small molecule screening identifies inhibitors of the Epstein-Barr virus deubiquitinating enzyme, BPLF1.

Authors:  Sage L Atkins; Safiyyah Motaib; Laura C Wiser; Sharon E Hopcraft; Paul B Hardy; Julia Shackelford; Peter Foote; Ashley H Wade; Blossom Damania; Joseph S Pagano; Kenneth H Pearce; Christopher B Whitehurst
Journal:  Antiviral Res       Date:  2019-11-08       Impact factor: 5.970

6.  Herpesvirus deconjugases inhibit the IFN response by promoting TRIM25 autoubiquitination and functional inactivation of the RIG-I signalosome.

Authors:  Soham Gupta; Päivi Ylä-Anttila; Simone Callegari; Ming-Han Tsai; Henri-Jacques Delecluse; Maria G Masucci
Journal:  PLoS Pathog       Date:  2018-01-22       Impact factor: 6.823

7.  Genetic factors affecting EBV copy number in lymphoblastoid cell lines derived from the 1000 Genome Project samples.

Authors:  Rajendra Mandage; Marco Telford; Juan Antonio Rodríguez; Xavier Farré; Hafid Layouni; Urko M Marigorta; Caitlin Cundiff; Jose Maria Heredia-Genestar; Arcadi Navarro; Gabriel Santpere
Journal:  PLoS One       Date:  2017-06-27       Impact factor: 3.240

Review 8.  The emerging role of Epstein-Barr virus encoded microRNAs in nasopharyngeal carcinoma.

Authors:  Chunmei Fan; Yanyan Tang; Jinpeng Wang; Fang Xiong; Can Guo; Yumin Wang; Bo Xiang; Ming Zhou; Xiayu Li; Xu Wu; Yong Li; Xiaoling Li; Guiyuan Li; Wei Xiong; Zhaoyang Zeng
Journal:  J Cancer       Date:  2018-07-30       Impact factor: 4.207

9.  Caspase-1 promotes Epstein-Barr virus replication by targeting the large tegument protein deneddylase to the nucleus of productively infected cells.

Authors:  Stefano Gastaldello; Xinsong Chen; Simone Callegari; Maria G Masucci
Journal:  PLoS Pathog       Date:  2013-10-10       Impact factor: 6.823

10.  Epstein-Barr virus large tegument protein BPLF1 contributes to innate immune evasion through interference with toll-like receptor signaling.

Authors:  Michiel van Gent; Steven G E Braem; Annemieke de Jong; Nezira Delagic; Janneke G C Peeters; Ingrid G J Boer; Paul N Moynagh; Elisabeth Kremmer; Emmanuel J Wiertz; Huib Ovaa; Bryan D Griffin; Maaike E Ressing
Journal:  PLoS Pathog       Date:  2014-02-20       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.